Riskpilot← Back to searchSign inGet full accessROMSDALSKLINIKKEN AS
ASActiveOrg 998755840Myrabakken 8, 6413 MoldeOther human health activities n.e.c. · NACE 8699Est. 20125 employees
Revenue 2024
NOK 2,2M
-8% vs 2023
EBITDA margin
1.1%
-88% vs 2023
Equity ratio
4.6%
Financial strength
Net profit 2024
NOK 19K
-87% vs 2023
| Revenue | NOK 2,2M | -8% |
| EBITDA | NOK 24K | -88% |
| Net profit | NOK 19K | -87% |
| Total assets | NOK 646K | -27% |
| Equity | NOK 30K | +0% |
| Employees | 5 | — |
Legal name
ROMSDALSKLINIKKEN AS
Org number
998755840
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
27. august 2012
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drive virksomhet innen helsefremmende tiltak, herunder fysioterapi, kiropaktikk, massasje, og salg av helseprodukter samt treningsrelaterte artikler, herunder annet som naturlig følger med slik virksomhet, samt delta i andre selskaper.
Address
Myrabakken 8, 6413 Molde
Phone
+4770332050
Email
info@romsdalsklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 030 | 2 228 | 2 164 | 2 409 | 2 217 |
| Staff expenses | −783 | −1 011 | −557 | −894 | −712 |
| EBITDA | 45 | −31 | 191 | 197 | 24 |
| Depreciation & amort. | −6 | −6 | −6 | −0 | −0 |
| EBIT | 39 | −37 | 185 | 197 | 24 |
| Net financials | −4 | −3 | −1 | −1 | 1 |
| Profit before tax | 36 | −40 | 184 | 196 | 25 |
| Tax | 9 | −9 | 42 | 45 | 5 |
| Net profit | 27 | −31 | 142 | 152 | 19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 843 | 847 | 1 110 | 887 | 646 |
| Equity | 142 | 137 | 30 | 30 | 30 |
| Long-term debt | 161 | 93 | 200 | 0 | 0 |
| Short-term debt | 540 | 617 | 880 | 857 | 616 |
| Total debt | 701 | 709 | 1 080 | 857 | 616 |
EBITDA margin
1.1%
This company
15.8%
Market median
-93% vs market
20202024
Equity ratio
4.6%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
64.8%
This company
18.4%
Market median
+252% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
3.43×
This company
1.12×
Market median
+206% vs market
20202024
Debt / equity
20.52×
This company
0.62×
Market median
-3210% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ML Deputy Member | Deputy Member | 2012 |
GP Chief Executive Officer | Chief Executive Officer | 2012 |
| Former (1) | ||
GP Chief Executive Officer | Chief Executive Officer | 2012 – 2023 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mgl Holding As
ROMSDALSKLINIKKEN AS Board members of ROMSDALSKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Lystad | Deputy Member | 0 companies |
| Gunnhild Pauline Lystad | Chief Executive Officer | 0 companies |
| Gunnhild Pauline Villa | Chief Executive Officer | 0 companies |